logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 제주지방법원 2017.02.16 2013가합5486
손해배상(의)
Text

1. The plaintiffs' claims against the defendants are all dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

Reasons

1. Facts of recognition;

A. The status of the party is 1) Defendant F is the I Hospital at H at Jeju Island (hereinafter “Defendant Hospital”).

(2) The Plaintiff is the husband of the Plaintiff, and the Plaintiff C, D, and E are children between Plaintiff A and B. The Plaintiff is the husband of the Plaintiff.

B. Plaintiff A, including Plaintiff A’s medical history, has been judged as having a physical disability grade II due to the cerebral chrophism that occurred in around 1994, in part the right arms, legs, and grandchildren. A around that time, Plaintiff A used her anti-cerebral chrosin, which is an anti-cerebral chrodism system, every day to prevent cerebral chrodism recurrence.

In addition, around January of 2011, there is a deficit in which the defendant hospital was hospitalized in the defendant hospital with the upper right color, and there was a brain stroke in February of 2012 and around October of 201, the defendant hospital was treated in the emergency room of the defendant hospital.

C. On March 3, 2013, at around 14:57, Plaintiff A applied the head to the emergency room of the Defendant hospital due to the symptoms where the left-hand arm’s length is worn down. As a result of the brain examination, Plaintiff A’s blood transfusion was expressed around approximately 7c in the vicinity of the right-hand spatho, and the INR value indicating the degree of blood compliance was raised by 3.21.21 (General INR No. 1 is considered normal, and the high level of blood exposure is likely to be flowed.

(2) Defendant G explained that the blood transfusion was likely to occur due to the overfachising to Plaintiff B, a guardian, and that the possibility of re-explosion is high, and subsequently, Plaintiff G suspended the overfachisinging of Plaintiff A’s overfachising and hospitalized Plaintiff A, and then administered Plaintiff A with B. 2) on March 5, 2013.

Defendant G determined that “the point at which the blood transfusion was completely absorbed and the blood transfusion cannot be seen in CT or MRI” should be viewed as the point at which cerebral blood is stable, and then re-divates the anti-cerebral blood system. The Plaintiff B whenever it comes to use it.

arrow